810106C

NBD AA

Avanti Research^™ - A Croda Brand 810106C

• 동의어(들): 20-[(7-nitro-2-1,3-benzoxadiazol-4-yl)amino] arachidonic acid
• 실험식(Hill 표기법): C₂₆H₃₄ N₄O₅
• CAS Number: 2254005-15-5
• Molecular Weight: 482.57
• UNSPSC 코드: 12352211
• NACRES: NA.25

속성

• 분석: >99% (TLC)
• 형태: liquid
• 포장: pkg of 1 × 1 mL (810106C-1mg)
• 제조업체/상표: Avanti Research^™ - A Croda Brand 810106C
• 농도: 1 mg/mL (810106C-1mg)
• 지질 유형: fluorescent lipids; bioactive lipids
• 배송 상태: dry ice
• 저장 온도: −70°C

설명

일반 설명

The endocannabinoid pathway influences behavior, lipogenesis, embryologic development, and pathophysiological effects including pain, inflammation, stress, obesity, and non-alcoholic fatty liver disease. Endogenous endocannabinoids including arachidonoylethanolamide (anandamide, AEA) and 2-arachidonoylglycerol (2-AG) are derived from arachidonic acid (AA). Fluorescent NBD-AA and NBD-AEA analogues are direct probes that can be used for visualizing the uptake, intracellular trafficking, and targeting of these molecules by living cells, as well as measuring the binding of endocannabinoids to cytosolic binding proteins. Importantly, direct binding studies show the affinities of the fluorescent analogues are in the same range as the respective unlabeled ligands. Fluorescent endocannabinoid probes are useful for mapping the impact of various treatments, inhibitors, etc on endocannabinoid uptake and distribution in living cells.

포장

5 mL Amber Glass Screw Cap Vial/Argon/Foil Bag 810106C-1mg)

법적 정보

Avanti Research is a trademark of Avanti Polar Lipids, LLC

안전성 정보

• 픽토그램: GHS06,GHS08
• 신호어: Danger
• 유해 및 위험 성명서: H302,H315,H319,H331,H336,H351,H361d,H372
• 예방조치 성명서: P260 - P280 - P301 + P312 + P330 - P304 + P340 + P311 - P305 + P351 + P338 - P403 + P233
• Hazard Classifications: Acute Tox. 3 Inhalation - Acute Tox. 4 Oral - Carc. 2 - Eye Irrit. 2 - Repr. 2 - Skin Irrit. 2 - STOT RE 1 - STOT SE 3
• 표적 기관: Central nervous system
• WGK: WGK 3